Overlook Hospital is a 504-bed non-profit teaching hospital located in Summit, New Jersey, United States, 20 miles west of New York City.

There are 504 beds in Overlook Hospital.

During the past decade, Overlook Hospital conducted 88 clinical trials. In the 10-year time frame, 88 clinical trials started and 125 clinical trials were completed, i.e. on average, 142% percent of trials that started reached the finish line to date. In the past 5 years, 31 clinical trials started and 47 clinical trials were completed. i.e. 151.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Overlook Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 82 trials, followed by "Children's Oncology Group" with 81 trials sponsored, "Alliance for Clinical Trials in Oncology" with 21 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 14 trials sponsored and "SWOG Cancer Research Network" with 14 trials sponsored. Other sponsors include 77 different institutions and companies that sponsored additional 52 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Overlook Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 159 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "NCIC Clinical Trials Group" with 9 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator and "Cancer and Leukemia Group B" with 6 trials as a collaborator. Other collaborators include 74 different institutions and companies that were collaborators in the rest 58 trials.

According to Clinical.Site data, the most researched conditions in "Overlook Hospital" are "Breast Cancer" (12 trials), "Sarcoma" (9 trials), "Acute Lymphoblastic Leukemia" (8 trials), "Lymphoma" (8 trials) and "Recurrent Breast Carcinoma" (8 trials). Many other conditions were trialed in "Overlook Hospital" in a lesser frequency.

Most popular intervention types in "Overlook Hospital" are "Drug" (220 trials), "Other" (141 trials), "Biological" (103 trials), "Procedure" (65 trials) and "Radiation" (53 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (82 trials), "Quality-of-Life Assessment" (40 trials), "Carboplatin" (28 trials), "Bevacizumab" (27 trials) and "Cyclophosphamide" (27 trials). Other intervention names were less common.

The vast majority of trials in "Overlook Hospital" are 245 trials for "All" genders, 38 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Overlook Hospital". undefined are not yet recruiting, 30 are recruiting, 93 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 128 completed trials in Overlook Hospital, 3 suspended trials, and 25 terminated clinical trials to date.

Out of the total trials that were conducted in Overlook Hospital, 12 "Phase 1" clinical trials were conducted, 103 "Phase 2" clinical trials and 150 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 14 trials that are defined as “Not Applicable".